No Data
No Data
Afternoon session [Active stocks and traded stocks]
* Aki Iijima <1997> 2160 +81 Operating profit for the first quarter increased by 46.6%. * Nextage <3186> 1473 +66 The forecast for increased profit this period brings reassurance. * Tobu Juhan <3297> 1107 +292 The performance estimate for the first half of the May 2025 period has been revised upward. * Ecomix <3802> 468 +60 Expanded the shareholder benefits program. * Fundely <3137> 380 +80 Announced the 'Fan Shareholder 0.02 million people plan'. * J Lease <7187> 1305 +44 Social healthcare.
Nextstage rebounds for the first time in three days, with a plan to increase the year-end Dividends for the fiscal year ending in November 2025 to a double-digit profit increase.
Nextage <3186.T> has rebounded for the first time in three days, briefly reaching 1,489 yen, an increase of 82 yen. After the close on the 6th, the consolidated financial estimates for the fiscal year ending November 2025 were announced. A two-digit profit growth outlook and a plan to increase year-end Dividends were well received. For the fiscal year ending November 2025, the forecasts are a revenue of 580 billion yen (an increase of 4.9% from the previous term) and an operating profit of 15 billion yen (an increase of 15.9% from the previous term). A consistent service ranging from vehicle sales to automotive accessories sales, Insurance, vehicle inspections, maintenance, sheet metal, repairs, and purchasing is offered.
Volume change rate ranking (9 AM) - Nextage, J-ATC, etc. are ranked.
In the volume change rate ranking, by comparing the average volume over the last 5 days with the volume on the day of distribution, it is possible to understand market participants' interests and trends in buying and selling. ■Top volume change rates [As of January 7, 9:36] (Comparison of average volume over the last 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <5572> Ridge Eye 7100 107185.08 -80.45% 0.0038%<
January 7 [Today's Investment Strategy]
[Fisco Selected Stock] 【Material Stock】 Asteria <3853> 529 yen (1/6) develops Software and services to connect Computers and devices within companies. The performance Financial Estimates for the fiscal year ending March 2025 have been revised. Operating profit is estimated at 0.6 billion yen. This is an increase of 9-50% from the previous estimate. The previous year had a deficit of 3.642 billion yen. The expected profits in the Software business compared to initial estimates are a contributing factor. Additionally, the policy for Shareholder returns has been changed, with the end-of-term Dividends set at 7.5 yen. The previous estimate was
Attention is focused on Asteria and Dai-Seki, while Azuwan and Nextage are showing weakness.
In the US stock market on the 6th, the Dow Jones Industrial Average fell by $25.57 to 42,706.56, the Nasdaq Composite Index rose by 243.30 points to 19,864.98, and the Chicago Nikkei 225 Futures were up 335 yen compared to the daytime in Osaka at 39,675 yen. The exchange rate was 1 dollar = 157.50-60 yen. In today's Tokyo market, Asteria <3853>, which revised its operating profit and Dividends Financial Estimates upward for the fiscal year ending March 2025, Dai-Seki <9793>, which revised its operating results and Dividends Financial Estimates upward for the fiscal year ending February 2025, and the Social Medical Corporation Seishinkai Sapporo Seiji.
<Today's individual materials> WOLVES, Canvas, Right-On, Dai-seki, ETC (Announced on the 6th)
▽WOLVES <194A.T> has resolved to acquire the operations of Yasuda Animal Hospital (Nishinomiya City, Hyogo Prefecture) and signed a business transfer agreement. ▽Canvas <4575.T> has received a patent grant from the U.S. Patent Office for the immunotherapy candidate compound "CBT005". ▽Right-On <7445.T> reported that same-store sales in December decreased by 15.4% compared to the same month last year, marking the tenth consecutive month below the previous year. ▽Daiseki S <1712.T> has reported the cumulative results for the third quarter of the period ending February 25 (March-November 24).
No Data